During the past decade, Vero Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vero Neurology" are "Epilepsy With Simple or Complex Partial Onset Seizures" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Orthostatic Hypotension" (1 trials), "Parkinson's Disease" (1 trials) and "Symptomatic Neurogenic Orthostatic Hypotension" (1 trials). Many other conditions were trialed in "Vero Neurology" in a lesser frequency.

Most popular intervention types in "Vero Neurology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Droxidopa" (1 trials), "Droxidopa capsules" (1 trials), "Eslicarbazepine acetate" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vero Neurology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Vero Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Vero Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vero Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".